Zoletil 100 250 mg - 250 mg Lyophilisat et solvant pour solution injectable
Zoletil 100 250 mg - 250 mg Lyophilisat et solvant pour solution injectable
Authorised
- Tiletamine hydrochloride
- Zolazepam hydrochloride
Product identification
Medicine name:
Zoletil 100 250 mg - 250 mg Lyophilisat et solvant pour solution injectable
Zoletil 100 250 mg - 250 mg Lyofilisaat en oplosmiddel voor oplossing voor injectie
Zoletil 100 250 mg - 250 mg Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung
Active substance:
- Tiletamine hydrochloride
- Zolazepam hydrochloride
Target species:
-
Cat
-
Dog
-
Wild animals
Route of administration:
-
Intravenous use
-
Intramuscular use
Product details
Active substance and strength:
-
Tiletamine hydrochloride290.80milligram(s)1.00Vial
-
Zolazepam hydrochloride281.80milligram(s)1.00Vial
Pharmaceutical form:
-
Powder and solvent for solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Cat
-
Dog
-
Wild animals
-
-
Intramuscular use
-
Dog
-
Cat
-
Wild animals
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Zoletil 100 250 mg - 250 mg Lyophilisate and solvent for solution for injection - Box with 10 vials with 970 mg lyophilisate and 10 vials with 5 ml solvent
- Zoletil 100 250 mg - 250 mg Lyophilisate and solvent for solution for injection - Box with 1 vial with 970 mg lyophilisate and 1 vial with 5 ml solvent
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac S.A.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V166896
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?: